Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have been assigned an average recommendation of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have issued a report […]